But yet you state "Strong Buy".
Do you understand how DUMB this looks?
Gosh you are an baffling buffoon!
I have been long SRPT for a while and it is doing well. Up 46% in the past 3 weeks from my entry.
Drisa was really dissed by Adcom and FDA comments, so I am doubtful that one will be approved.
Eteplirsen has a better chance in my opinion.
Ete will only target 13% of the DMD population, but their pipeline is specializing in DMD exon skippin tech which pretty much makes this a Rare disease pharma and if you take a look at RARE for example --- did pretty well this year.
As for CTIX --- thank goodness that they saw value in Polymedix assets as Brilacidin has been kind of a lifesaver in the "dead periods" of Kevetrin dosing.
Prurisol --- I really don't know. Very interested in hearing updates on that one.
It's tough through all the Manipulation and Fraud that goes on to stay positive.
Things tend to work out in the long run.
Lee believes and this guy love him or not, has never been down about CTIX.
Look, a good company cannot be held down forever. This years been a rough one and I didn't see it being manipulated this much.
Had my fam thanksgiving a few days ago, so just chillin at home watching movies.
Take care all.
to write some kind of bashing article. This is just the lack of class this guy displays.
Just remember his articles are to manipulate one way or the other period.
It's NEVER fair and balanced unless he is attempting to reconcile his own rep.
I believe the TRT market will grow. I don't think it will be long before this drug takes off. Just send a fax to every endocrinologist and try and hit the as many clinics as possible...it will sell itself.
Dr's have been long awaiting the Pill form.
I would imagine a lot of manipulation between now and then, but one day this should establish a higher base as if this is approved they could possibly make this market cap the first year.
Always have some dry powder for the big pullbacks.
Ctixer --- always in a hurry to make money. Sounds alright by me!
It is just a matter of time here. I don't think this will occur as it would be out of the norm to do this prior to knowing more data.
Yes, I agree he made it very clear that a PIVOTAL is being conceived.
Good things to come!!
Supposedly the FDA Encouraged SRPT to file after the longer term studies were positive.
Why would the FDA ENCOURAGE a company to file?
was on CNBC about a half hour ago hinted that she believes at least one of these will be approved.
It's pretty obvious that E is much better than D.
The pressure is really on the FDA to do something.
AF doesn't know his head from his azss. He doesn't do enough research and his main job is to cause confusion so his "family of thieves" can manipulate.
Dystrophin production increases over 100% as opposed to barely measurable to dris.
BLRX has a 12% stake in BLRX at an average of $2.00. They will be presenting at ASH and I believe NVS will collaborate on their pipeline and could even add more to their stake?
It is sitting at $1.28 right now.
4 Companies I like in that space right now are: CPXX, BLRX, TRIL and TGTX.
Fraz --- send me an email for a company I absolutely Love for 2016.
Torks me off when I write something and it doesn't post or is deleted.
Bottom Line: There is MUCH more news coming on the entire pipe.
should be coming on syn-004 and IBS.
The IBS could be a game changer in the IBS market...seriously. We don't know yet, but that's why I am excited because there has not been a trial like this.
SYN-004 --- that in my opinion is a blockbuster in the making and someday the stock will reflect big time.
Trimesta --- now we have the proof needed that a Phase III is verified, now who wants it?
Pertussa--- we should hear news on this soon also, finally we may find out how this one works.
XON- new collaborations likely also.
Plus: The small bio sector is finally catching fire again.